ARCHIVES

Senate Committee Schedules Hearing for FDA Acting Commissioner von Eschenbach.

This article is from The Cancer Letter archive.

Vol. 32 No. 29 | July 28, 2006

Download PDF Visit The Full Archive

Related Articles

Caris Officials Respond To Questions Submitted By The Cancer Letter

August 8, 2014

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

March 25, 2011

Switch T CD-Rom To Save PDQ $1 Mil. Over Five Years

September 14, 1990

NCAB Wants NCI To Avoid Setting Guidelines Regarding Health Policy

March 4, 1994

In Brief: Cooper Wouldn’t Take NIH Job, Says No One Has Asked Him To Take Top Health Spot

February 7, 1975

Bush Nominates von Eschenbach For FDA; Democrats Put Hold On Confirmation. von Eschenbach To Step Down As NCI Director, But Details Unavailable; No Acting Director Named. Applause, Outrage, Over Nomination. Now, von Eschenbach Leads A Retreat From 2015 Target Date For His Challenge Goal.

March 17, 2006